The Sentinel Within: Exploiting the Immune System for Cancer Biomarkers-Reference-Cited by-同舟云学术

The Sentinel Within: Exploiting the Immune System for Cancer Biomarkers

Published:2005-06-18 Issue:4 Volume:4 Page:1123-1133
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Anderson Karen S.¹,LaBaer Joshua¹

Affiliation:

1. Dana-Farber Cancer Institute, Harvard Medical School, Boston Massachusetts, and Harvard Institute of Proteomics, Harvard Medical School, Boston Massachusetts 02115

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr0500814

Reference121 articles.

1. A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer

2. The Telomerase Catalytic Subunit Is a Widely Expressed Tumor-Associated Antigen Recognized by Cytotoxic T Lymphocytes

3. The major substrates for TAP in vivo are derived from newly synthesized proteins

Cited by 281 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profiling of autoantibodies in the sera of glioblastoma patients;Immunotherapy;2024-09-12

2. Autoantibodies in cancer: a systematic review of their clinical role in the most prevalent cancers;Frontiers in Immunology;2024-08-21

3. Anti-BIRC5 autoantibody serves as a valuable biomarker for diagnosing AFP-negative hepatocellular carcinoma;PeerJ;2024-05-31

4. P53 Gene as a Promising Biomarker and Potential Target for the Early Diagnosis of Reproductive Cancers;Cureus;2024-05-11

5. Autoantibodies in laryngeal cancer: detection and role as a biomarker;Laboratory Medicine;2024-02-13